Rankings
▼
Calendar
PLSE FY 2023 Earnings — Pulse Biosciences, Inc. Revenue & Financial Results | Market Cap Arena
PLSE
Pulse Biosciences, Inc.
$1B
FY 2023 Earnings
Healthcare
Medical - Instruments & Supplies
Income Statement
Revenue
$0
-100.0% YoY
Gross Profit
-$1M
Operating Income
-$44M
Net Income
-$42M
EPS (Diluted)
$-0.88
Cash Flow
Operating Cash Flow
-$33M
Free Cash Flow
-$33M
Stock-Based Comp.
$7M
Balance Sheet
Total Assets
$59M
Total Liabilities
$15M
Stockholders' Equity
$44M
Cash & Equivalents
$44M
Year-over-Year Comparison
Metric
Current
Year Ago
Change
Revenue
$0
$700,000
-100.0%
Gross Profit
-$1M
-$11M
+89.3%
Operating Income
-$44M
-$58M
+24.9%
Net Income
-$42M
-$59M
+27.9%
← Q4 2022
All Quarters
Q1 2023 →